Advanced search

Report side effect

Report a suspected side effect or falsified product to the MHRA Yellow Card scheme.
Go to {yellow_card_logo} site
{arrow_up} Back to top

Hemgenix {equilateral_black_triangle}

Active Ingredient:
etranacogene dezaparvovec
Company:  
CSL Behring UK Limited See contact details
ATC code: 
B02BD16
{info_black}
About Medicine
{medical_services}
Prescription only medicine
Healthcare Professionals (SmPC) Patient Leaflet (PIL) Risk Materials HCP Med Info
{arrow_left}
{arrow_right}

Educational Risk Minimisation Materials to help reduce the risk associated with using this medicine.

{pdf_link}

Hemgenix Healthcare Professional Guide

{healthcare_pro_orange} For Healthcare Professionals

Important risk minimisation information for healthcare professionals

{pdf_link}

Hemgenix Patient Card

This patient alert card should be used by patients who have been prescribed Hemgenix and should carry with them at all times when taking this medicine.

{pdf_link}

Hemgenix Patient Guide

Information for parents and carers of patients prescribed Hemgenix

You are trying to reach document intended for healthcare professionals only.

Are you a healthcare professional?

Log in or sign up to avoid further verifications.

CSL Behring UK Limited
Company image
Address
4 Milton Road, Haywards Heath, West Sussex, RH16 1AH, UK
WWW
http://www.cslbehring.co.uk
Telephone
+44 (0)1444 447 400
Fax
+44 (0)1444 447 403
Medical Information Direct Line
+44 (0)1444 447 405
Medical Information e-mail
[email protected]
Customer Care direct line
+44 (0)1444 447 402
Out of Hours contact
+44 (0)1444 447 405